Keywords: BP, bullous pemphigoid; ELISA, enzyme-linked immunosorbent assay; PD-1, programmed death receptor-1; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; bullous pemphigoid; pembrolizumab; toxic epidermal necrolysis.